EC Number |
Inhibitors |
Structure |
---|
3.4.21.61 | (3S,4S,5S,6R)-2-([(2R,3S,4S,5S,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-methoxytetrahydro-2H-pyran-4-yl]amino)-6-(hydroxymethyl)tetrahydro-2H-thiopyran-3,4,5-triol |
i.e. BJ-12-26-1, greatly reduces the processing of substrate proopiomelanocortin |
|
3.4.21.61 | (3S,4S,5S,6R)-2-([(2S,3S,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3-yl]amino)-6-(hydroxymethyl)tetrahydro-2H-thiopyran-3,4,5-triol |
i.e. BJ-12-21-2, greatly reduces the processing of substrate proopiomelanocortin |
|
3.4.21.61 | 5alpha,6alpha-epoxy-(22E,24R)-ergosta-8(14),22-diene-3beta,7beta-diol |
isolated from fruiting bodies of Sparassis crispa |
|
3.4.21.61 | Ac-R-E-R-K-chloromethylketone |
alternate binding site and resultant displacement of the scissile bond in the active site results in a decrease in the acylation rate |
|
3.4.21.61 | adenosine |
- |
|
3.4.21.61 | Ala-Lys-Arg boronic acid |
- |
|
3.4.21.61 | Ala-Lys-Arg chloromethyl ketone |
- |
|
3.4.21.61 | Berberine |
- |
|
3.4.21.61 | CT-peptide |
decreases PC1/3 activity at high concentrations (micromol) |
|
3.4.21.61 | D-Tyr-Ala-Lys-Arg-CH2Cl |
- |
|